FLT4 and skin cancer: Consistently, our findings demonstrate that the novel and simply prepared anti-VEGFR3 peptide is able to significantly block the VEGF-C/VEGFR3 pathway, which further inhibits cancer stemness, migration and invasion in skin cancer cells.